Nephros Statistics
Total Valuation
Nephros has a market cap or net worth of $16.24 million. The enterprise value is $15.27 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nephros has 10.54 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 10.54M |
| Shares Outstanding | 10.54M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 12.34% |
| Owned by Institutions (%) | 6.49% |
| Float | 5.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| Forward PS | 1.08 |
| PB Ratio | 1.99 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.18.
| Current Ratio | 6.95 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -480.00 |
Financial Efficiency
Return on equity (ROE) is -11.06% and return on invested capital (ROIC) is -6.29%.
| Return on Equity (ROE) | -11.06% |
| Return on Assets (ROA) | -5.63% |
| Return on Capital (ROIC) | -6.29% |
| Revenue Per Employee | $436,968 |
| Profits Per Employee | -$29,968 |
| Employee Count | 31 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 1.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.80% in the last 52 weeks. The beta is 1.19, so Nephros's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -47.80% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 47.62 |
| Average Volume (20 Days) | 9,796 |
Short Selling Information
The latest short interest is 7,656, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 7,656 |
| Short Previous Month | 7,693 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Nephros had revenue of $13.55 million and -$929,000 in losses. Loss per share was -$0.09.
| Revenue | 13.55M |
| Gross Profit | 8.27M |
| Operating Income | -960,000 |
| Pretax Income | -1.29M |
| Net Income | -929,000 |
| EBITDA | -807,000 |
| EBIT | -960,000 |
| Loss Per Share | -$0.09 |
Full Income StatementBalance Sheet
The company has $2.46 million in cash and $1.49 million in debt, giving a net cash position of $965,000 or $0.09 per share.
| Cash & Cash Equivalents | 2.46M |
| Total Debt | 1.49M |
| Net Cash | 965,000 |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 8.17M |
| Book Value Per Share | 0.78 |
| Working Capital | 6.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.03 million and capital expenditures -$130,000, giving a free cash flow of -$2.16 million.
| Operating Cash Flow | -2.03M |
| Capital Expenditures | -130,000 |
| Free Cash Flow | -2.16M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 61.04%, with operating and profit margins of -7.09% and -6.86%.
| Gross Margin | 61.04% |
| Operating Margin | -7.09% |
| Pretax Margin | -6.86% |
| Profit Margin | -6.86% |
| EBITDA Margin | -5.96% |
| EBIT Margin | -7.09% |
| FCF Margin | n/a |
Dividends & Yields
Nephros does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | -5.72% |
| FCF Yield | -13.32% |
Analyst Forecast
The average price target for Nephros is $5.00, which is 224.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.00 |
| Price Target Difference | 224.68% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 10, 2019. It was a reverse split with a ratio of 0.1111111:1.
| Last Split Date | Jul 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1111111:1 |
Scores
Nephros has an Altman Z-Score of -11.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.03 |
| Piotroski F-Score | 3 |